Home > Insider Trading > Filing (0001225208-13-013426)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
105770	West Pharmaceutical Services Inc	WST	Fabricated Rubber Products, Nec (3060)	231210010

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1213306	Jr E Donald Morel	530 Herman O. West Drive Exton PA 19341	Chair Of The Board & Ceo	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2013-05-23	100,825	$41.70	603,993	No	4	M	Direct
Common Stock	Acquisiton	2013-05-23	96,576	$44.97	700,569	No	4	M	Direct
Common Stock	Disposition	2013-05-23	79,142	$67.61	621,427	No	4	F	Direct
Common Stock	Disposition	2013-05-23	79,995	$67.61	541,432	No	4	F	Direct
Common Stock	Disposition	2013-05-28	5,000	$68.04	536,432	No	4	S	Direct
Common Stock	Disposition	2013-05-28	5,000	$67.70	531,432	No	4	S	Direct
Common Stock	Acquisiton	2013-05-24	19	$67.38	20,527	No	4	A	Indirect	Non-Qualified Deferred Compensation Plan

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct
No	4	S	Direct
No	4	A	Indirect	Non-Qualified Deferred Compensation Plan

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2013-05-23	100,825	$41.70	100,825	$41.70
Common Stock	Stock Option (Right to Buy)	Disposition	2013-05-23	96,576	$44.97	96,576	$44.97

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2009-02-26	2018-02-26	No	4	M	Direct
0	2008-02-27	2018-02-27	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,336	Indirect	By Savings Plan

Footnotes

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.48 to $68.30, inclusive. The reporting person undertakes to provide to any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in foonotes (1) and (2) to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $67.45 to $67.98, inclusive.